HEMODYNAMIC-RESPONSE TO MOLSIDOMINE IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY TOLERANT TO ISOSORBIDE DINITRATE

被引:18
|
作者
UNGER, P
LEONE, A
STAROUKINE, M
DEGRE, S
BERKENBOOM, G
机构
[1] UNIV LIBRE BRUXELLES, ERASME HOSP, DEPT CARDIOL, 808 ROUTE LENNIK, B-1070 BRUSSELS, BELGIUM
[2] UNIV LIBRE BRUXELLES, BRUGMANN HOSP, DEPT CARDIOL, B-1070 BRUSSELS, BELGIUM
关键词
NITRATE TOLERANCE; ISOSORBIDE DINITRATE; MOLSIDOMINE; ENALAPRIL;
D O I
10.1097/00005344-199112000-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Unlike nitrates, molsidomine is able to relax vascular smooth muscle without depending on the availability of sulfhydryl groups. To assess the clinical relevance of this property, the hemodynamic effects of a 24-h i.v. infusion of molsidomine were studied in 14 patients with ischemic cardiomyopathy rendered tolerant to i.v. isosorbide dinitrate. In order to determine the role of neurohormonal activation, six of these patients were studied in the presence of an angiotensin-converting enzyme (ACE) inhibitor (enalapril, 5 mg, b.i.d.) (group 2). Six patients out of eight in group 1 (without ACE inhibition) and all patients in group 2 responded to molsidomine with a marked reduction of pulmonary artery wedge pressure (PAWP) (49% +/- 5 and 50% +/- 4 versus baseline value, respectively). However, the reduction of PAWP in group 1 was no longer significant at 12 h, and at 24 h the loss of the peak effect reached 67% +/- 7. On the contrary, PAWP remained persistently reduced in group 2 (loss of peak effect, 20 % +/- 3 at 24 h, p < 0.005). In addition, a significant decrease in hematocrit and increase in epinephrine occurred in group 1 but not in group 2. These results suggest that both the absence of dependence on sulfhydryl groups and the blockade of neurohormonal reactions are needed to avoid nitrate tolerance.
引用
下载
收藏
页码:888 / 894
页数:7
相关论文
共 50 条
  • [21] COMPARATIVE HEMODYNAMIC EFFECTS OF ORAL AND SUBLINGUAL ISOSORBIDE DINITRATE IN PATIENTS WITH CORONARY INSUFFICIENCY
    POLINER, L
    RITTER, W
    WOHL, A
    NIXON, JV
    WILLERSON, JT
    CLINICAL RESEARCH, 1976, 24 (01): : A5 - A5
  • [22] Hemodynamic time course of acute and chronic isosorbide dinitrate treatment at rest and during exercise in patients with stable ischemic heart disease
    Jorgensen, LH
    Thaulow, E
    Refsum, HE
    CLINICAL CARDIOLOGY, 1996, 19 (09) : 718 - 724
  • [23] HEMODYNAMIC-EFFECTS OF ORAL ISOSORBIDE-5-MONONITRATE AND DINITRATE IN ISCHEMIC HEART-FAILURE
    RABINOWITZ, B
    HOD, H
    CHOURAQUI, P
    RATH, S
    AGRANAT, O
    NEUFELD, HN
    CLINICAL CARDIOLOGY, 1987, 10 (10) : 603 - 608
  • [24] INFLUENCES OF MOLSIDOMINE, ISOSORBIDE DINITRATE (ISDN), VERAPAMIL, AND PLACEBO ON THE EXERCISE TOLERANCE IN PATIENTS WITH CORONARY-ARTERY DISEASE
    BOHM, H
    HERZ KREISLAUF, 1988, 20 (06): : 237 - 241
  • [25] DIFFERENT HEMODYNAMIC ACTIONS OF TRINITROGLYCERIN AND ISOSORBIDE DINITRATE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    REZAKOVIC, D
    RUTISHAUSER, W
    PAVICIC, L
    POPADIC, M
    BLOCH, A
    IMHOFF, EW
    EUROPEAN HEART JOURNAL, 1983, 4 (10) : 718 - 723
  • [26] Molsidomine and isosorbide dinitrate: A comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort
    Alimova, EV
    Martsevich, SY
    Kutishenko, NP
    Metelitsa, VI
    TERAPEVTICHESKII ARKHIV, 1997, 69 (12): : 37 - 40
  • [27] NEUROHUMORAL PROFILE DETERMINES HEMODYNAMIC-RESPONSE TO BETA-BLOCKADE IN CONGESTIVE CARDIOMYOPATHY
    BINKLEY, PF
    LEWE, R
    LEIER, CV
    CLINICAL RESEARCH, 1986, 34 (02): : A283 - A283
  • [28] HEMODYNAMIC-RESPONSE TO PHYSICAL STRESS IN PATIENTS WITH VALVULAR REPLACEMENT
    BENDET, YA
    VERICH, NM
    DOLOMAN, LB
    KARDIOLOGIYA, 1987, 27 (04) : 104 - 105
  • [29] HEMODYNAMIC-RESPONSE TO INTRAVENOUS EPHEDRINE IN PEDIATRIC-PATIENTS
    TAGUCHI, N
    NISHIKAWA, T
    YAMASHITA, S
    NAITO, H
    ANESTHESIA AND ANALGESIA, 1994, 78 (02): : U226 - U226
  • [30] HEMODYNAMIC-RESPONSE TO INTRAVENOUS NITROGLYCERIN IN PATIENTS WITH UNSTABLE ANGINA
    BATENHORST, RL
    BOTTORFF, MB
    BOOTH, D
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 504 - 504